India to Japan: Nivolumab Export Trade Route

The India to Japan Nivolumab corridor is one of India's established pharmaceutical export routes, with 15 shipments documented worth a combined $28.7K USD. The route is dominated by MODERN DRUG HOUSE, which alone accounts for roughly 100% of all export value, reflecting the consolidated nature of India's nivolumab manufacturing sector.

Across 1 active suppliers, the average shipment value stands at $1.9K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Freight is split between sea (66%) and air (16%), suggesting a mix of scheduled bulk orders and time-sensitive consignments.

Shipment activity peaks during April–June, with an average transit time of 26 days port-to-port. The route has recorded an annual growth rate of 22.8%, placing it at rank #6 among India's top nivolumab export destinations globally.

On the import side, key buyers of Indian nivolumab in Japan include TO THE ORDER OF-, TO, THE ORDER OF, TO,THE ORDER OF and 3 others. TO THE ORDER OF- is the single largest importer with 4 shipments valued at $10.9K USD.

India's nivolumab exports to Japan are driven primarily by a handful of large-scale manufacturers. MODERN DRUG HOUSE with 15 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 1 active exporters signals a competitive but concentrated market — buyers in Japan benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — MODERN DRUG HOUSE — together account for 100% of total trade value on this route. The average shipment value of $1.9K USD reflects a mix of bulk commercial orders and smaller specialty shipments.

Beyond the primary product category, shipments on this route include closely related formulations such as pharmaceutical harmless injection nivolumab injection 10mg/ml, brand : opdyta 100ml and pharmaceutical harmless injection nivolumab injection 10mg/ml, 10ml vial brand :opdyta 100mg, suggesting that buyers in Japan tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, TO THE ORDER OF- is the largest importer with 4 shipments worth $10.9K USD — representing 38% of all nivolumab imports from India on this route. A total of 6 buyers are active on this corridor.